| 1 |
Partly verified |
Full text not readStored summary read |
N01 · Efficacy comparison · Preserved-material preparationWhat are the selected long-term question and original subclaim verdict?Required |
The selected preserved account concerns maintained superiority at five years, original grade D, with the note that the difference of -0.80 kg and 95% CI -2.13 to 0.54 was a null result. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Original wording, grade/note and parent context for maintained superiority at five years |
Distinguish the original long-term verdict from the parent one-year verdict. |
| 2 |
Partly verified |
Full text not readStored summary read |
N02 · Efficacy comparison · Preserved-material preparationWhat duration and comparison does long-term superiority concern?Required |
The five-year result is the WRAP 52- versus 12-week weight difference. Both groups received access to the same active WW program for different durations. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Five-year between-group comparison of allocation to program access for 52 versus 12 weeks |
Present allocated program-access duration separately from five-year assessment timing. |
| 3 |
Partly verified |
Full text not readStored summary read |
N03 · Efficacy comparison · Preserved-material preparationWhich original-trial population does five-year follow-up concern?Required |
The original trial enrolled 1,267 adults with BMI at least 28 in UK primary care; the five-year bibliography concerns follow-up of the same WRAP trial. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Linkage between original allocation and long-term follow-up eligibility/observed populations |
Link the original recruited population with long-term observed/analysis populations. |
| 4 |
Partly verified |
Full text not readStored summary read |
N04 · Efficacy comparison · Preserved-material preparationAre original allocation denominators distinguished from long-term denominators?Required |
Original allocation denominators were 211 for brief intervention, 528 for 12 weeks and 528 for 52 weeks. The 823 with measured weight at 12 months concern one year. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Group-specific allocation, follow-up, measurement and analysis denominators |
Separate original allocation, one-year observation and five-year observation denominators. |
| 5 |
Unverified |
Full text not readStored summary read |
N05 · Efficacy comparison · Preserved-material preparationAre long-term missingness, attrition and imputation assumptions verified?Required |
The original materials describe 35% missing measured weight at 12 months and multiple imputation. Long-term bibliography and the five-year effect are present, but five-year missingness details are absent. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Five-year follow-up losses, group-specific reasons, models and sensitivity analysis |
Present missingness materials and assumptions separately for each time point. |
| 6 |
Partly verified |
Full text not readStored summary read |
N06 · Efficacy comparison · Preserved-material preparationAre the original intervention identity and research exposure retained?Required |
The parent intervention is the WW program with one group meeting per week for 52 weeks; the comparator also received access to the same program for 12 weeks. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
52- and 12-week program, meetings, access and actual-use specifications |
Retain the identities of the research exposure and long-term assessment. |
| 7 |
Unverified |
Full text not readStored summary read |
N07 · Efficacy comparison · Preserved-material preparationAre additional exposure and cross-group program use after the program known?Required |
Five-year follow-up assessment is recorded, but participants’ subsequent program use and other weight-management exposure are absent from the summary. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Post-program weight management, program use, co-exposure and changes |
Distinguish the original period from subsequent exposure. |
| 8 |
Partly verified |
Full text not readStored summary read |
N08 · Efficacy comparison · Preserved-material preparationAre the definition and measurement methods for five-year weight verified?Required |
The long-term summary presents the five-year 52- versus 12-week weight difference in kg. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Assessment timing, equipment, actual measurement, units and assessors |
Present measurement timing, units and methods together. |
| 9 |
Partly verified |
Full text not readStored summary read |
N09 · Efficacy comparison · Preserved-material preparationWhat difference and interval were directly reported at five years?Required |
The preserved account states a five-year difference of -0.80 kg, 95% CI -2.13 to 0.54, a null result. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Selected between-group difference, confidence interval and analysis comparison |
Present the original difference/interval together with the absence of test information. |
| 10 |
Partly verified |
Full text not readStored summary read |
N10 · Efficacy comparison · Preserved-material preparationHas a null result been recast as exact zero or equivalence?Required |
The original subclaim and parent counterview state that the five-year difference was null and durable superiority was not established. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Superiority question, effect interval, original interpretation and equivalence criteria |
Distinguish unestablished superiority from the scope of an equivalence claim. |
| 11 |
Partly verified |
Full text not readStored summary read |
N11 · Efficacy comparison · Preserved-material preparationAre maintained weight loss within each group and between-group superiority the same question?Required |
The preserved long-term value is a 52- versus 12-week between-group weight difference. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Actual group-specific baseline, change, maintenance and between-group differences |
Separate within-group maintenance from relative between-group superiority. |
| 12 |
Partly verified |
Full text not readStored summary read |
N12 · Efficacy comparison · Preserved-material preparationHave original 12-month results been reused as long-term results?Required |
At 12 months, changes were -4.75 kg for 12 weeks and -6.76 kg for 52 weeks; adjusted difference -2.14 kg, 95% CI -3.05 to -1.22, P<.0001. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Time-specific separation of one-year and five-year comparisons |
Present positive 12-month and null five-year results separately. |
| 13 |
Partly verified |
Full text not readStored summary read |
N13 · Efficacy comparison · Preserved-material preparationAre 24-month and five-year results kept separate?Required |
The 24-month difference is described as -1.32 kg, 95% CI -2.46 to -0.18, P=.0231, a different time point from five years. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Actual estimates, denominators and analyses for intermediate and long-term comparisons |
Present results separately for intermediate and long-term time points. |
| 14 |
Unverified |
Full text not readStored summary read |
N14 · Efficacy comparison · Preserved-material preparationAre the long-term effect of interest and analysis model known?Required |
The preserved counterview and subclaim note contain a five-year between-group difference and CI; details of the long-term model are absent. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Adjustment, covariates, analysis population and estimand for the five-year comparison |
Distinguish time-specific estimands and missingness assumptions. |
| 15 |
Partly verified |
Full text not readStored summary read |
N15 · Efficacy comparison · Preserved-material preparationAre original allocation and five-year follow-up masking/selection effects distinguished?Required |
The original evidence describes a three-arm randomized controlled trial; the five-year citation concerns follow-up of the same trial. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Original allocation, follow-up participation, assessor roles and attrition |
Present retained original allocation together with limitations of follow-up selection. |
| 16 |
Partly verified |
Full text not readStored summary read |
N16 · Efficacy comparison · Preserved-material preparationHave the prespecified long-term endpoint plan and hierarchy been read?Required |
The original primary endpoint was weight at one year, and prespecified hierarchical testing describes one-year comparisons; the long-term bibliography concerns five-year follow-up. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Long-term assessment plan, SAP, plan changes and multiplicity documents |
Distinguish the original primary plan from long-term plans/reporting. |
| 17 |
Partly verified |
Full text not readStored summary read |
N17 · Efficacy comparison · Preserved-material preparationAre registration identifiers separated from actual reading of registration/plans?Required |
The identifier is ISRCTN82857232, and the original summary states registration preceded recruitment. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Actual ISRCTN registration, pre-recruitment plan and long-term update materials |
Present the original identifier separately from planning materials for each time point. |
| 18 |
Partly verified |
Full text not readStored summary read |
N18 · Efficacy comparison · Preserved-material preparationHave sample-size assumptions or important differences become long-term criteria?Required |
The original study describes a sample of 1,200 and a 1.3 kg detection assumption, while stating this was not a declared minimum clinically important difference. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Original criteria for five-year importance, power and precision |
Distinguish one-year detection assumptions from long-term judgment criteria. |
| 19 |
Partly verified |
Full text not readStored summary read |
N19 · Efficacy comparison · Preserved-material preparationHas long-term weight comparison been extended to clinical, functional or economic outcomes?Required |
The follow-up citation title mentions effectiveness and cost-effectiveness, but the preserved result concerns five-year weight comparison. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Direct results for weight versus disease, function and economic endpoints |
Present weight superiority separately from other direct endpoints. |
| 20 |
Partly verified |
Full text not readStored summary read |
N20 · Efficacy comparison · Preserved-material preparationHave follow-up reports from the same cohort been counted as independent replication?Required |
The 2017 main report and 2022 five-year follow-up concern the same WRAP trial; the original citation flag identifies long-term follow-up of the same trial. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Linkage of main report, follow-up, registration and sibling sheets |
Separate report slots from independent-trial and participant units. |
| 21 |
Partly verified |
Full text not readStored summary read |
N21 · Efficacy comparison · Preserved-material preparationIs there evidence for other independent long-term replication or other programs?Required |
The current preserved summary identifies the main and long-term reports of the same WRAP trial. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Independent long-term follow-up of the same question and direct setting-specific comparisons |
Distinguish follow-up in the same cohort from gaps in independent long-term replication. |
| 22 |
Partly verified |
Full text not readStored summary read |
N22 · Efficacy comparison · Preserved-material preparationAre original-trial industry, public and nonprofit support all retained?Required |
Public/nonprofit joint funding, Weight Watchers International industry-partner funding and program-access provision are all recorded. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Funding, program-access support and industry-partner relationships |
Distinguish original-trial support from follow-up-report support. |
| 23 |
Partly verified |
Full text not readStored summary read |
N23 · Efficacy comparison · Preserved-material preparationHas research funding received by authors’ institutions become company-employee authorship?Required |
The preserved account states that institutions of five authors disclosed receipt of WW research funding. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Institutional support, employment, author contributions and conflicts of interest |
Separate institutional support from employment relationships and individual roles. |
| 24 |
Unverified |
Full text not readStored summary read |
N24 · Efficacy comparison · Preserved-material preparationAre analysis, medical writing, publication fees and data/publication control known?Required |
The summary provides mixed funding, program access and institutional-support relationships; the complete long-term analysis/writing/publication roles are absent. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Original/follow-up sponsor and author role disclosures |
Record reported support separately from unverified roles. |
| 25 |
Partly verified |
Full text not readStored summary read |
N25 · Supplementary harm evidenceHas the main report’s intervention-related adverse-event account become five-year harms evidence?Supplementary |
The safety summary states that no intervention-related adverse events were reported, while an all-event table by group was absent. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Long-term event collection, definitions, group denominators and causal classification |
Separate the main-report safety statement from long-term harms materials. |
| 26 |
Partly verified |
Full text not readStored summary read |
N26 · Supplementary harm evidenceDoes a null five-year result also establish equal safety between durations?Supplementary |
The original advertising interpretation and safety explanation explicitly limit extension to long-term maintenance or equal safety. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Direct long-term harms comparisons, denominators, intervals and plans |
Separate the weight-superiority question from safety comparison. |
| 27 |
Unverified |
Full text not readStored summary read |
N27 · Supplementary harm evidenceIs the observation scope sufficient to judge long-term and rare harms?Supplementary |
Long-term bibliography is present, but safety details in the preserved summary are limited. Parent Good safety is an original-verdict record. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Materials on long-term exposure, attrition, rare events and vulnerable populations |
Present long-term weight observation separately from rare-harm gaps. |
| 28 |
Partly verified |
Full text not readStored summary read |
N28 · Efficacy comparison · Preserved-material preparationHas the current five-year follow-up full text actually been read?Required |
What was actually read was the complete parent preserved summary. The five-year citation’s Cambridge repository URL and main-report PubMed URL are linked as preserved. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Access distinctions between preserved summary, follow-up repository, abstracts, full texts, registration and plans |
Display summary reading separately from external nonreading. |
| 29 |
Partly verified |
Full text not readStored summary read |
N29 · Efficacy comparison · Preserved-material preparationAre reference dates, corrections, Korean/English and axes distinct from the selected long-term verdict?Required |
The complete summary retains parent Korean/English, axes, 2026-08-26 reference date, empty corrections/deliberation and the long-term subclaim. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Complete original parent and original long-term subclaim |
Distinguish parent history, long-term subclaim and preparation date. |
| 30 |
Partly verified |
Full text not readStored summary read |
N30 · Efficacy comparison · Preserved-material preparationAre candidate states and the existing selected unit distinct from preparation/content review?Required |
The selected existing subclaim is prepared while distinguishing question and verdict-record links. Candidate pending, eligibility and independence labels are retained as original-selection history. |
Preparation displays information, scope and unverified matters in the read preserved materials; this is not completed content review or a new clinical efficacy/harms verdict. |
Question/record links, historical candidate values and condition-freeze/application events |
Display saved preparation separately from user content review and clinical certification. |